ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Dynamic Alterations of BMP9 in NAFLD: A Novel Hepatokine Marker of Metabolic Dysfunction and Disease Severity.
Fan Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.